Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP

Richard Miller is a professor of pathology and the Director of the Center for Aging Research at the University of Michigan. He is one of the architects of the NIA-funded Interventions Testing Programs (ITPs) animal study test protocol. In this episode, Rich goes through the results of the long list of molecules tested by the ITP—including rapamycin, metformin, nicotinamide riboside, an SGLT-2 inhibitor called canagliflozin, and more. Many of the discussed outcomes have had surprising outcomes—both positive and negative findings. We discuss: 00:00:00 - Intro 00:03:45 - Rich’s interest in aging, and how Hayflick’s hypothesis skewed aging research 00:15:00 - Dispelling the myth that aging can’t be slowed 00:29:00 - The Interventions Testing Program—A scientific framework for testing whether drugs extend lifespan in mice 00:38:45 - Testing aspirin in the first ITP cohort 00:44:45 - Rapamycin: results from ITP studies, dosing considerations, and what it tells us about early- vs. late-life interventions 01:07:15 - Acarbose as a potential longevity agent by virtue of its ability to block peak glucose levels 01:15:45 - Resveratrol: why it received so much attention as a longevity agent, and the takeaways from the negative results of the ITP study 01:24:15 - The value in negative findings: ITP studies of green tea extract, methylene blue, curcumin, and more 01:27:00 - 17α-Estradiol: lifespan effects in male mice, and sex-specific effects of different interventions 01:33:15 - Testing ursolic acid and hydrogen sulfide: rationale and preliminary results 01:35:45 - Canagliflozin (an SGLT2 inhibitor): exploring the impressive lifespan results in male mice 01:42:30 - The failure of metformin: reconciling negative results of the ITP with data in human studies 01:48:45 - Nicotinamide riboside: insights from the negative results of the ITP study 01:55:30 - The three most important takeaways from the ITP studies 01:59:30 - Philosophies on studying the aging process: best model organisms, when to start interventions, which questions to ask, and more 02:08:00 - Seven reasons why pigs can't fly Show notes page: https://peterattiamd.com/richardmiller/ About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com/ Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/ Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/ Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Play: http://bit.ly/TheDriveGooglePlay

Dr. Richard Millerguest
Feb 8, 20212h 14mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

At a glance

WHAT IT’S REALLY ABOUT

Richard Miller on the ITP: Which Drugs Truly Extend Mouse Lifespan

  1. Miller explains that the ITP runs in parallel at three sites using large numbers of genetically heterogeneous mice, giving statistically powerful and reproducible tests of whether a drug extends lifespan.
  2. Rapamycin, acarbose, 17α-estradiol and canagliflozin extended lifespan, and several of them worked even when started in middle age, which Miller says overturned his own expectation that interventions must start young.
  3. Many results were sex-specific: 17α-estradiol, canagliflozin, acarbose and NDGA mainly helped males, while rapamycin stood out for its strong effect in both sexes.
  4. Resveratrol, metformin, nicotinamide riboside, aspirin at higher doses, green tea extract and others failed to extend lifespan in the ITP, which Miller treats as valuable findings that temper popular hype.
  5. Miller argues the field should ask what can slow aging as a whole rather than what causes it, and he criticizes the Hayflick-limit and telomere frameworks as poor proxies for aging.

IDEAS WORTH REMEMBERING

5 ideas

Aging can be slowed by drugs in food

Miller's first takeaway is that ITP results show a dietary drug can extend healthy lifespan by an amount he calls ten times better than curing cancer, which should reorient medical research toward drugs that slow aging.

The ITP is built for reliability

It uses about 50 males and 50 females per drug at each of three sites, doubled controls, and genetically heterogeneous Het3 mice, so that results are powerful and reproducible rather than artifacts of one lab or one inbred strain.

Interventions can work when started in middle age

Rapamycin started at 20 months worked about as well as an early start, 17α-estradiol worked similarly when started late, and acarbose worked about half as well, which Miller says contradicted his own prediction.

Effects are often sex-specific

Miller notes that 17α-estradiol, canagliflozin and acarbose mainly help males, while rapamycin and glycine work in both sexes, and he calls understanding why an important research question.

Blunting glucose peaks may matter

Acarbose and canagliflozin both extend male lifespan and block peak glucose without lowering hemoglobin A1C in mice, though Miller cautions that canagliflozin may act through mechanisms other than glucose.

WORDS WORTH SAVING

5 quotes

I don't really care what causes aging. What I care about is what is the process that can postpone all the different aspects of aging.

— Dr. Richard Miller

You've got to be at least three times better than a complete conquest of cancer.

— Dr. Richard Miller

I bet that it was a waste of time and money to give rapamycin to 20-month-old mice, to middle-aged mice. I said, "This can't possibly work." And they were right, of course, and I was completely wrong, and that's a big surprise.

— Dr. Richard Miller

The first point I'd make is the one we began at the beginning of this conversation, which is that, by gosh, you actually can put something in the food that extends healthy lifespan, and it's an enormous effect, ten times better than a cure for cancer.

— Dr. Richard Miller

If you don't ask the right question, you are guaranteed to flail. You know, you might get lucky, but you're, you're gonna flail.

— Dr. Peter Attia

Interventions Testing Program designGenetically heterogeneous miceRapamycin and mTOR complexesLate-life interventionsSex-specific drug effectsAcarbose and canagliflozin and glucose peaksNegative results: resveratrol, metformin, NR

High quality AI-generated summary created from speaker-labeled transcript.

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.